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T ile underlying etiology of heart fMlure may entail 
_It" structural, l)iochemical, or 1)hysiologic abnormal- 
ities. Regardless of the initiating insult, the heart com- 
pensates with a numl)cr of acute adaptive lncchanisms 
to maintain adequate cardiac outl)ut, ] illclu(ling car- 
diac dilation and activation of ncurohormones to main- 
tain arterial 1)ressure and 1)erfusion of vital organs. 2
The chronic effect of these compensatory changes is 
maladaptive, resulting in structural and functional 
changes to the heart known as relnodehng. 9 Remod- 
eling is a well-established halhnarl,: in :lie progression 
of heart failure. 
Several factors Call stimulate the renlodeling process, 
including ncurohormonal activation and mechanical 
stress. The compensatory ventricular dilation increases 
l)iomcchanical wall stress and causes stretching of the 
cardiac myoeytes. 't Such stretching induces maht(lal)tive 
changes in gene exllression and stimulation of autocrine/ 
lmracrine neurohormonal ctivity, with adverse ffects on 
the extracelhdar matrix, and possilde promotion of myo- 
cyte ai)ol)tosis. 1,5,6 Once begun, the remodeling process is 
autoinductive, leading to flwther remodeling and ~dthout 
intervention, inexorable progression of ventricular (lys- 
function to end-stage heart failure. 
One surgical intervention for heart failure is the Acorn 
cardiac support device (CSD). This mesh-like imldantable 
device is surgically positioned aroun(! the heart and ad- 
justed to provide circumferential diastolic support. The 
CSD is intended to reduce wall stress and myocyte over 
stretch during end-diastole and l)criodic hcmodynalnic 
overload conditions. ]{educing or limiting the stress all(l 
stretch on the myoeardium nmy halt or even reverse a key 
component of the remodeling process. 
The Acorn CSD (Fig I) is a mesh-like polyester fabric 
constructed of muhifilamentous yarn to l)rovide high 
strength and fatigue-resistant characteristics while 
maintaining flexibility. The knit construction imparts 
teat" and ravel resistance. The device is designed with 
bidirectional compliance to conform to the heart and 
help reshape it to a more ellipsoidal shape. The CSD is 
available in six sizes; the tinal fitting for the specific 
heart is performed by the surgeon. 
Patients currently considered appropriate candi- 
dates for CSD therapy are adults with systolic heart 
failure of either ischemic or nonisehemic origin who 
may or may not require standard cardiac surgical pro- 
cedures uch as mitral vah'e repair/replacement or cor- 
Fig I. Cardiac support device structure. (Top) Actual size 
of 5-ram section. (Bottom) Polyester weave that reduces 
stretching in transverse dimension more than in longitudinal 
axis (30• nlagnifieation). 
onary artery bylmss grafting (CABG). They have left 
ventricular dilation with a New York Itcart Association 
(1X~qtA) functional class between late II and early IV. 
The Acorn CSD is contraindicated in patients with 
primary diastolic dysflmction or restrictive disease. 
Previous cardiac surgery is not a contraindication, 
unless lmtent coronary artery grafts might be compro- 
mised lly the presence of the CSD or adhesions might 
prevent proper CSD placenlent. Patients in end-stage 
NYIIA class IV receiving continuous intravenous car- 
diac medications or mechanical support are too ill for a 
therapy that is not intended to provide immediate he- 
modynamic improvement; likewise, patients with too 
many comorbidities may be too high risk to benefit 
from CSD th@apy, in general, a candidate's urgical 
risk shouhl lm considered reasonable. 
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][ If the CSD is used as solo therapy, off-punqr placement is preferred. The device can also Ire 
implanted in conjunction with other rel)arative operations that mandate ardiopulmonary b pass 
including coronary artery bypass urgery. In these cases, device implant shouhl Ire started with tire 
patient on pump support to facilitate placement of the posterior atriovcntricular (AV) groove 
Slllrlr'CS, 
Aftcr stcrnotomy, the pericardium is opened and the diameter of the left ventricle at the 
midpapiilary muscle level is measured using trauscophagcal cehoeardiography (TEE). The heart is 
l)rclmrcd for device placement by creating a perieardial cradle. We generally use a technique 
advocated by many off-pump CABG surgeons. The right-sided pericardium is excised infcriorly 
along the diaphragm. The right side of the pericardium is left flaccid while the left-side pericardial 
edge is rctractcd up toward the sternum to lrcgin the rotation of tile heart toward the right. Two 2-0 
Teflon-coaled Dacron sutures are plaectl in tile pcricar(lium adjacent o the left superior and 
inferior puhuonary veins. As these sutures are retracted toward the sterntun, tlre cardiac apex is 
rotated toward the patient's right chest. The patient is rotated to the right to facilitate positioning 
of the heart and exposure of the posterior AV groove. The anesthesia team monitors and adjusts the 
patient's volume load t~) ensure adcqrmte hemodynamics and stable heart size during tim implant 
procedure. (A) Either before or after completion of the pericardial cradle, a measuring tape or cord 
is placed around the heart at the hase to al)proximate the heart's circumference. (B) The same tool 
can also Ire used to estimate the length of the heart from base to apex anteriorly. These two 
measurements arc usc([ to select he al)l)rOlu-iatc-sizcd CSD according to the manufacturer's sizing 
chart. 
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Once chosen, the CSD is positioned around the ventricles, with lmrticular care taken to ensure 
that the hemline lies over or just below the AV groove. A series of 4-0 l~olypropylene sutures are 
used to secure the material in place (A). We generally use four sutures posteriorly located at the left 
atrial api)endage, medial to the inferior vena eava, and in between these two sites over the coronary 
sinus. Next, the device is wrapped over the apex and palled to the AV groove anteriorly (B). 
Additional 4-0 1;olylwopylene sutures are placed in the AV fat pad on the left lateral aspect of the 
heart as the mesh is pulled tautly into apposition with the heart. In a similar fashion, sutures ecure 
the mesh medially above the right coronary artery. Care shouhl be taken to avoid injuring the 
epicardial vessels. Because only the epieardium is needed to provide adequate strength to hohl the 
mesh in place, deep sutures are discouraged. Excess fabric is accumulated anteriorly in prepara- 
tion for final fitting of the device. 
The device is adjusted to fit snugly around the ventricles and cause a slight reduction in 
circumference of heart, thus ensuring that the CSD relieves a portion of mechanical stress in the 
ventrieular wall (C). We seek to reduce the diameter of the heart (as measured by TEE) by 5%, but 
vigorously avoid any reduction greater than 10% to xninimize the risk of any adverse vents related 
to device fit. A specialized clamp is used to secure the mesh as it is pulled taut over the right 
ventricle (B, C, D). Once TEE confirms the desired degree of reduction, excess lnaterial above the 
clamp is excised and the mesh is resutured using 4-0 polyprol~ylene (D, E, F). The clamp is 
removed, the new anterior seam is reinforced, and the mesh is secured cireumferentially with 
placement of the final .'interior stay sutures. 
Coln l l l{~l l |S  
Progressive heart  fai lure is character ized by loss of 
car(l iae function associated with maladaptive changes 
in myocardia l  gene exllression and neuroendocr ine ac- 
tivity, leading to a progressive increase in heart  size. 
Elevated ventr icu lar  wall stress resulting from an in- 
crease in ehaml)er size is thought to play a role ilk 
further ing (levelopment towards end-stage disease. Re- 
duction of wall stress may be an important  way of 
nfitigating heart  fai lure progression. One possillle all- 
l)roach to accomplish this goal is through passive con- 
tainment of the heart  with tile Acorn CSD. 
Because prosthetic medical devices implanted in the 
body general ly elicit some level of host response, a 
natura l  concern is whether  tile CSD 1)romotes develop- 
ment of constrictive physiology. Animal and clinical 
studies sui)l)ort tile view that tile CSD does not promote  
develol lment of a constr ict ive l lattern. 7 Precl inical  
studies indicate no signs of a constrictive l lattern based 
on analysis of filling pressures and pressure-vohnue 
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loop analys isg ~Clinical s tudy  resuhs  also ind icate that  
pat ients  receiv ing the CSD do not  exhibit  a constr ic t ive  
9 9 phys io logy.  
A l though the tissue react ion between the CSD and  
the hear t  does not  appear  to eontr i l )ute to constr ic t ive  
phys io logy,  a reasonab le  concern  is whether  the CSD 
could l t revent  o r  conq)l icate fu ture  card iac  o l )erat ions.  
Sur face  f ibrosis associated with the CSD may in ter fe re  
with v isual izat ion of  card iac  a rch i tec ture ,  inchnding 
el) icardial  coronary  arter ies ,  shou ld  redo  surgery ,  such 
as CABG,  be requ i red .  
In  pat ients  with signif icant mi t ra l  valve regurg i ta -  
t ion, mi t ra l  valve repa i r  o r  rep lacement  may be per -  
for lned in con junct ion  with CSD iml, lantatiol l .  These  
two l ) rocedures  have been successful ly l )er formed con-  
comitant ly  in more  than 50 pat ients  to (late with slight 
modi f icat ions to the CSD imphmt  procedure .  The  CSD 
may reduce  mi t ra l  valve regurg i tat ion  wi thout  valve 
surgery .  The  CSD's  b id i rect ional  compl iance  design 
promotes  a t 'eshaping of  the hear t  f rom a more  s l ,her-  
ical to a lnore elli l)soidal shape.  This allows rea lq)rox i -  
mat ion  of  the vahdar  al) l )aratus to reduce  mit ra l  regur -  
gitat ion. 
In  conc lus ion ,  the Acorn  CSD prov ides  a promis ing  
surgical  therapy  fo r  di lated card iomyopathy .  Based on 
extensive prec l in ica l  studies,  the CSD not  only hahs  
vent r ieu la r  d i lat ion but  also apl ,ears  to l)ronlote ven-  
t r i cu lar  reverse remode l ing  wi thout  any  safety issues. 
S imi lar  results  a rc  ref lected in the initial safety studies 
with up to 2 -year  pat ient  fo l low-up.  These  resuhs  in(li- 
cate that  the CSD is a safe product  with t rends toward  
iml)rove(|  card iac  funct ion and pat ient  benefit .  Based  
on these studies,  ran( lomized cl inical tr ials are  cur -  
rent ly  underway  in Euro l , c  and  Nor th  Amer ica .  This  
surgical  ap l , roach  l , rovides addi t ional  ev idence sup-  
por t ing  aggressive malmgement  of vent r i cu la r  emode l -  
ing in the t reatment  o f  hear t  fai lure. 
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